GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.3752
-0.0143 (-3.67%)
At close: May 8, 2026, 4:00 PM EDT
0.3955
+0.0203 (5.41%)
After-hours: May 8, 2026, 7:49 PM EDT
GT Biopharma Employees
GT Biopharma had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$34,449,000
Market Cap
11.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | -1 | -50.00% | 1 | 0 |
| Dec 31, 2023 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2022 | 2 | -6 | -75.00% | 2 | 0 |
| Dec 31, 2021 | 8 | 5 | 166.67% | 8 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| Passage Bio | 24 |
| BioCardia | 21 |
| Moleculin Biotech | 17 |
| Intensity Therapeutics | 7 |
| Phio Pharmaceuticals | 6 |
| Jupiter Neurosciences | 5 |
| Kairos Pharma | 4 |
GTBP News
- 9 days ago - GT Biopharma files to sell 9.72M shares of common stock for holders - TheFly
- 23 days ago - GT Biopharma Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts
- 2 months ago - GT Biopharma price target lowered to $3 from $8 at Roth Capital - TheFly
- 2 months ago - GT Biopharma price target lowered to $3 from $8 at Roth Capital - TheFly
- 2 months ago - GT Biopharma expects cash to fund operations through Q4 2026 - TheFly
- 2 months ago - GT Biopharma Reports Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - GT Biopharma to Present at the Centurion One Capital 9th Annual Toronto Growth Conference - GlobeNewsWire
- 3 months ago - GT Biopharma announces FDA clearance of IND application for GTB-5550 - TheFly